TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 14(Homo sapiens (Human))
Proteostasis Therapeutics
US Patent
Proteostasis Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:Usp14 Inhibition Assay was described in B. H. Lee et al. Nature 2010, 467 (9), 179.More data for this Ligand-Target Pair